Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Condition:   Tuberous Sclerosis
Interventions:   Drug: GNX oral suspension, TID;   Drug: Placebo
Sponsor:   Marinus Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 16, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments